Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma

Published:2020 Issue:3 Volume:9 Page:358-360
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Matsuki Ryota,Kawai Kirio,Suzuki Yutaka,Kogure Masaharu,Nakazato Tetsuya,Naruge Daisuke,Okano Naohiro,Seki Satowa,Ohmori Yoshihiko,Kawamura Naohiro,Kamma Hiroshi,Hisamatsu Tadakazu,Shibahara Junji,Mori Toshiyuki,Furuse Junji,Sakamoto Yoshihiro

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference5 articles.

1. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010 Feb;30(1):52–60.

2. Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018 Mar;391(10126):1163–73.

3. Irtan S, Chopin-Laly X, Ronot M, Faivre S, Paradis V, Belghiti J. Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection. Liver Int. 2011 May;31(5):740–3.

4. Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec;30(36):4566–72.

5. Lencioni R, Montal R, Torres F, Park JW, Decaens T, Raoul JL, et al. Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. J Hepatol. 2017 Jun;66(6):1166–72.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of liver resection in the era of advanced systemic therapy for hepatocellular carcinoma;Global Health & Medicine;2024-06-30

2. A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report;Clinical Journal of Gastroenterology;2024-01-26

3. レンバチニブ及び放射線治療後の再肝切除による集学的治療が奏功した門脈腫瘍栓を伴う早期再発肝細胞癌の1例;Kanzo;2023-12-01

4. A Case of Giant Hepatocellular Carcinoma Successfully Treated with Lenvatinib Followed by Parenchymal-Sparing Hepatectomy;The Japanese Journal of Gastroenterological Surgery;2023-10-01

5. Histological findings of thyroid cancer after lenvatinib therapy;Histopathology;2023-07-28